Stuttgart - Delayed Quote EUR
Krystal Biotech, Inc. (4KB.SG)
116.40
-0.35
(-0.30%)
At close: May 16 at 9:33:39 PM GMT+2
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 8 | 8 | 10 | 10 |
Avg. Estimate | 97.54M | 108.22M | 417.15M | 608.46M |
Low Estimate | 92.6M | 103.2M | 404.1M | 509.23M |
High Estimate | 106.96M | 118M | 448M | 765.5M |
Year Ago Sales | 70.28M | 83.84M | 290.51M | 417.15M |
Sales Growth (year/est) | 38.78% | 29.08% | 43.59% | 45.86% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
4KB.SG | -- | -- | -- | -- |
S&P 500 | 13.21% | 2.76% | 7.83% | 13.78% |
Upgrades & Downgrades
Maintains | Citigroup: Neutral to Neutral | 5/16/2025 |
Maintains | Guggenheim: Buy to Buy | 5/7/2025 |
Maintains | Chardan Capital: Buy to Buy | 5/7/2025 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 5/6/2025 |
Maintains | HC Wainwright & Co.: Buy to Buy | 4/29/2025 |
Maintains | HC Wainwright & Co.: Buy to Buy | 4/28/2025 |
Related Tickers
SRZN Surrozen, Inc.
7.10
+3.65%
CTNM Contineum Therapeutics, Inc.
3.5100
-10.91%
ENGN enGene Holdings Inc.
3.4500
+1.47%
INTS Intensity Therapeutics, Inc.
0.4200
-16.00%
CLGN CollPlant Biotechnologies Ltd.
1.7300
-1.14%
KLRS Kalaris Therapeutics, Inc.
3.4800
-1.69%
OKUR OnKure Therapeutics, Inc.
2.0000
-2.91%
AVTX Avalo Therapeutics, Inc.
3.9100
+1.30%
ACRV Acrivon Therapeutics, Inc.
1.1500
+4.55%
PRTA Prothena Corporation plc
7.18
+6.92%